VA Evidence Synthesis Program Coordinating Center, VA Portland Health Care System, 3710 SW US Veterans Hospital Road R&D 71, Portland, OR, 97239, USA.
VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.
J Gen Intern Med. 2024 Oct;39(13):2543-2553. doi: 10.1007/s11606-024-08852-1. Epub 2024 Jul 17.
There is growing concern that pulse oximeters are routinely less accurate in hospitalized patients with darker skin pigmentation, in turn increasing risk of undetected (occult) hypoxemia and adverse clinical outcomes. The aim of this systematic review and meta-analysis was to synthesize evidence on racial and ethnic disparities in occult hypoxemia prevalence and clinical impacts of undetected hypoxemia.
Ovid MEDLINE, Embase, and CINAHL databases were searched for relevant articles published through January 2024. Eligible studies must have been conducted among adults in inpatient or outpatient settings and report occult hypoxemia prevalence stratified by patient race or ethnicity, or clinical outcomes stratified by patient race or ethnicity and occult hypoxemia status. Screening for inclusion was conducted independently by two investigators. Data extraction and risk of bias assessment were conducted by one investigator then checked by a second. Outcome data were synthesized using random-effects meta-analyses.
Fifteen primary studies met eligibility criteria and reported occult hypoxemia prevalence in 732,505 paired oximetry measurements from 207,464 hospitalized patients. Compared with White patients, occult hypoxemia is likely more common among Black patients (pooled prevalence ratio = 1.67, 95% CI 1.47 to 1.90) and among patients identifying as Asian, Latinx, Indigenous, multiracial, or other race or ethnicity (pooled prevalence ratio = 1.39, 95% CI 1.19 to 1.64). Findings from studies reporting clinical outcomes suggest that Black patients with undetected hypoxemia may experience poorer treatment delivery outcomes than White patients with undetected hypoxemia. No evidence was found from outpatient settings.
This review and included primary studies rely on self-identified race or ethnicity, which may obscure variability in occult hypoxemia risk. Findings underscore that clinicians should be aware of the risk of occult hypoxemia in hospitalized patients with darker skin pigmentation. Moreover, oximetry data from included studies suggests that the accuracy of pulse oximeters could vary substantially from patient to patient and even within individual patients.
PROSPERO ( CRD42023402152 ).
人们越来越担心,脉搏血氧仪在肤色较深的住院患者中通常准确性较低,这反过来又增加了未检测到(隐匿性)低氧血症和不良临床结局的风险。本系统评价和荟萃分析的目的是综合评估隐匿性低氧血症患病率的种族和民族差异以及未检测到低氧血症的临床影响。
在 Ovid MEDLINE、Embase 和 CINAHL 数据库中检索了截至 2024 年 1 月发表的相关文章。符合条件的研究必须在住院或门诊环境中进行,并且必须报告根据患者的种族或族裔分层的隐匿性低氧血症患病率,或者根据患者的种族或族裔和隐匿性低氧血症状态分层的临床结局。两名研究者独立进行纳入筛选。一名研究者进行数据提取和风险偏倚评估,然后由第二名研究者进行核对。使用随机效应荟萃分析综合结局数据。
15 项主要研究符合纳入标准,报告了 207464 名住院患者的 732505 对血氧仪测量结果中的隐匿性低氧血症患病率。与白人患者相比,黑人患者隐匿性低氧血症更常见(汇总患病率比=1.67,95%CI 1.47 至 1.90),而亚裔、拉丁裔、原住民、多种族或其他种族或族裔的患者也更常见(汇总患病率比=1.39,95%CI 1.19 至 1.64)。报告临床结局的研究结果表明,与白人患者相比,未检测到低氧血症的黑人患者的治疗结果可能更差。在门诊环境中没有发现证据。
本综述和纳入的主要研究依赖于自我报告的种族或族裔,这可能掩盖了隐匿性低氧血症风险的变化。研究结果强调,临床医生应该意识到肤色较深的住院患者中隐匿性低氧血症的风险。此外,纳入研究的血氧仪数据表明,脉搏血氧仪的准确性可能会因患者而异,甚至在单个患者中也会有很大差异。
PROSPERO(CRD42023402152)。